Valuation: DocMorris AG

Market Cap 539M 655M 571M 490M 917M 62.84B 921M 6.46B 2.49B 31.95B 2.46B 2.41B 103B P/E 2026 *
-6.62x
P/E 2027 * -15.2x
Enterprise Value 742M 901M 785M 673M 1.26B 86.42B 1.27B 8.88B 3.43B 43.94B 3.38B 3.31B 141B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.55x
Free-Float
62.21%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
7.45
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
422.96
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 655M
-0.06%+4.37%-46.23%-9.54% 14.75B
-1.02%+2.24%-16.86%-6.90% 6.34B
-4.89%-2.50%-55.41%-35.00% 6.31B
+0.13%+1.33%-9.67%-22.89% 4.12B
+0.06%0.00%-19.61%-37.77% 3.13B
+0.38%+3.84%+6.00%-29.71% 3.12B
-1.05%+9.67%-43.95%-22.01% 2.93B
-0.13%+3.09%+76.92% - 2.85B
-1.19%-2.68%-21.86%-10.64% 2.38B
Average -3.45%+2.08%-14.52%-21.81% 5.1B
Weighted average by Cap. -1.20%+2.65%-25.75%-18.58%

Financials

2026 *2027 *
Net sales 1.26B 1.53B 1.34B 1.15B 2.15B 147B 2.16B 15.11B 5.83B 74.74B 5.75B 5.63B 240B 1.41B 1.71B 1.49B 1.28B 2.39B 164B 2.4B 16.83B 6.49B 83.25B 6.41B 6.27B 268B
Net income -85.9M -104M -90.98M -78.01M -146M -10.01B -147M -1.03B -397M -5.09B -392M -383M -16.38B -38.94M -47.29M -41.24M -35.36M -66.25M -4.54B -66.52M -466M -180M -2.31B -178M -174M -7.42B
Net Debt 202M 246M 214M 184M 344M 23.58B 346M 2.42B 935M 11.99B 923M 903M 38.57B 232M 282M 246M 211M 395M 27.05B 397M 2.78B 1.07B 13.75B 1.06B 1.04B 44.25B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
10.68CHF
Average target price
11.29CHF
Spread / Average Target
+5.75%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!